Clinical Trials Listing Service

Non-Alcoholic Fatty Liver Disease

Last updated: N/A
Sponsor: N/A
Overall Status: Active - Recruiting

Phase

2

Condition

Liver Disorders

Treatment

N/A

Clinical Study ID

TX238354
  • Ages 18-100
  • All Genders

Study Summary

The Effect of Vitamin E and Docosahexaenoic Acid Ethyl Ester on Non- alcoholic Fatty Liver Disease (NAFLD) - A radomized, doubleblind, placebo- controlled, parallel-group clinical trial.

Eligibility Criteria

Inclusion

  • Male or Female who are 18 or older
  • A recent (<4 years) diagnosis of fatty liver by imaging or by liver biopsy
  • Stable weight for the past 3 months

Study Design

Study Start date:
Estimated Completion Date:

Study Description

Connect with a study center

  • Advanced Pharma - Miami

    Miami, Florida 33147
    United States

    Active - Recruiting

  • Advanced Pharma - Miami

    Miami, Florida 33147
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.